Agimexpharm Pharmaceutical JSC

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Agimexpharm Pharmaceutical JSC"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 9.40% vs 5.54% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 12.09% vs 4.81% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "793,261.20",
          "val2": "725,130.10",
          "chgp": "9.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "122,108.40",
          "val2": "122,994.60",
          "chgp": "-0.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "29,377.20",
          "val2": "35,448.40",
          "chgp": "-17.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "44,905.20",
          "val2": "40,061.80",
          "chgp": "12.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "113.70%",
          "val2": "127.40%",
          "chgp": "-1.37%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

793,261.20

725,130.10

9.40%

Operating Profit (PBDIT) excl Other Income

122,108.40

122,994.60

-0.72%

Interest

29,377.20

35,448.40

-17.13%

Exceptional Items

0.00

0.00

Consolidate Net Profit

44,905.20

40,061.80

12.09%

Operating Profit Margin (Excl OI)

113.70%

127.40%

-1.37%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 9.40% vs 5.54% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 12.09% vs 4.81% in Dec 2023

All Annual Results